Patent · US Active

Antibodies to quetiapine haptens and use thereof

US10465013B2 · kind B2 · utility

0Cited by

31References

14Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Eric Hryhorenko · Hilton, US
Banumathi Sankaran · Lexington, US
Thomas R. DeCory · Pittsford, US
Theresa Tubbs · Rochester, US
Linda Colt · Rochester, US
Bart M. Remmerie · Evergem, BE
Rhys Salter · Doylestown, US
Matthew G. Donahue · Hattiesburg, US
Yong Gong · Warrington, US

Key dates

Filing date	Dec 18, 2017
Grant date	Nov 5, 2019
Priority date	—
Expiry date	Dec 18, 2037

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/9466
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Disclosed is an antibody which binds to quetiapine, which can be used to detect quetiapine in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of quetiapine, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.